Programmed cell removal by calreticulin in tissue homeostasis and cancer.

TitleProgrammed cell removal by calreticulin in tissue homeostasis and cancer.
Publication TypeJournal Article
Year of Publication2018
AuthorsFeng M, Marjon KD, Zhu F, Weissman-Tsukamoto R, Levett A, Sullivan K, Kao KS, Markovic M, Bump PA, Jackson HM, Choi TS, Chen J, Banuelos AM, Liu J, Gip P, Cheng L, Wang D, Weissman IL
JournalNat Commun
Volume9
Issue1
Pagination3194
Date Published2018 08 10
ISSN2041-1723
KeywordsAdult, Aged, Aged, 80 and over, Animals, Binding Sites, Calreticulin, Cell Line, Tumor, Cell Membrane, Cell Survival, Cellular Senescence, Female, Hematopoiesis, Homeostasis, Humans, Ligands, Macrophages, Male, Mice, Middle Aged, Neoplasms, Neutrophils, Phagocytosis, Polysaccharides
Abstract

Macrophage-mediated programmed cell removal (PrCR) is a process essential for the clearance of unwanted (damaged, dysfunctional, aged, or harmful) cells. The detection and recognition of appropriate target cells by macrophages is a critical step for successful PrCR, but its molecular mechanisms have not been delineated. Here using the models of tissue turnover, cancer immunosurveillance, and hematopoietic stem cells, we show that unwanted cells such as aging neutrophils and living cancer cells are susceptible to "labeling" by secreted calreticulin (CRT) from macrophages, enabling their clearance through PrCR. Importantly, we identified asialoglycans on the target cells to which CRT binds to regulate PrCR, and the availability of such CRT-binding sites on cancer cells correlated with the prognosis of patients in various malignancies. Our study reveals a general mechanism of target cell recognition by macrophages, which is the key for the removal of unwanted cells by PrCR in physiological and pathophysiological processes.

DOI10.1038/s41467-018-05211-7
Alternate JournalNat Commun
PubMed ID30097573
PubMed Central IDPMC6086865
Grant ListK99CA201075/R00CA201075 / / U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) / International
T32DK098132 / / U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) / International
R01CA086017 / / U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) / International
R00 CA201075 / CA / NCI NIH HHS / United States
R56AI118464 / / U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) / International
P01CA139490 / / U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) / International
R56 AI118464 / AI / NIAID NIH HHS / United States
DFS-22-16 / / Damon Runyon Cancer Research Foundation (Damon Runyon) / International